Glysure

GlySure is leading the way toward improved glycaemic control with the world’s first CE-marked intravascular continuous glucose monitor (CGM). GlySure is enabling critical care physicians to provide enhanced glycaemic control, which has been shown to improve patient outcomes, reduce risk to patients and reduce costs.

Amadeus contact

Anne Glover